Furthermore, ITIH4 also suppressed IL-5 and IL-13 levels in the intestinal tissues of OVA-induced asthma mice (p < 0.05; Fig. 3d), suggesting a systemic immunomodulatory effect that extends beyond the lungs. This evidence concerns the gene IL5 and asthma.